Medicine & TechnologyA new metric for obesity diagnosis called a body shape index or ABSI, which takes into account gender, weight, age, height, and weight circumference appears to be a more effective tool.
A new injectable drug for diabetes has earned FDA approval for long-term weight loss treatment - marking the agency's first approval for the application since 2014.
New research suggests that overweight or obese people who drink more alcohol are at greater risk of developing liver diseases compared to those with a healthy weight who consumed alcohol at the same level.
A study shows that despite having a higher BMI range if fat people live active lifestyles will have lower cardiovascular disease risks than people in the same weight levels that don't exercise.
Semaglitude, a medicine used to treat Type 2 diabetes, has now been found to be a game-changing drug for weight loss in patients that struggle with obesity.
A study among children in Amazonian Ecuador suggests that poor diet is the most likely risk factor underlying childhood obesity rather than the lack of physical activity.
Lipocalin-2 or LCN2, a type of hormone, could be used as a possible treatment in individuals with obesity whose natural indications for feeling full are no longer working.
For years, researchers have been looking for specific genes associated with obesity. Instead, they found non-coding RNA called microRNA which is linked to metabolic disease and digestion of milk.
Since the pandemic, researchers have reported how people's mental and physical health has declined during the lockdown and home quarantine. The first global survey analyzes these aspects in greater detail, especially for people with obesity.